Approach to the Patient: Diagnostic Challenges in the Workup for Polycystic Ovary Syndrome.
Level 5 - mechanism / opinion, no new human data
Narrative review and clinical guidance article without systematic review methodology
PubMed 39836632 · doi:10.1210/clinem/dgae910
What was done
This is a clinical guidance narrative review detailing the etiology, diagnostic criteria, and clinical challenges encountered during the diagnostic workup for polycystic ovary syndrome (PCOS) based on the International PCOS Guideline criteria.
What was found
The abstract reports that PCOS affects 10% to 13% of women globally. In adults, diagnosis requires meeting at least 2 of 3 criteria: (1) clinical or biochemical hyperandrogenism, (2) irregular cycles, and (3) polycystic ovary morphology or elevated anti-Müllerian hormone (AMH) levels. The abstract presents no original empirical findings or quantitative comparative test metrics.
Why it matters
It summarizes current consensus-based diagnostic criteria for PCOS and outlines how clinical heterogeneity, life-stage variations, and ethnic differences complicate routine diagnosis.
Limits
The abstract describes a narrative review without original human subject data, systematic literature search methodology, or quantitative diagnostic accuracy metrics (e.g., sensitivity or specificity).
Cited by
- supports High testosterone levels in blood are not required to diagnose PCOS if clinical symptoms of hyperandrogenism are present.